Article
The CYP2D6 humanized mouse: effect of the human CYP2D6 transgene and HNF4alpha on the disposition of debrisoquine in the mouse.
Molecular pharmacology - 1 Dec 2001
Corchero J, Granvil C P, Akiyama T E, Hayhurst G P, Pimprale S, Feigenbaum L, Idle J R, Gonzalez F J
Abstract excerpt
CYP2D6 is a highly polymorphic human gene responsible for a large variability in the disposition of more than 100 drugs to which humans may be exposed. Animal models are inadequate for preclinical pharmacological evaluation of CYP2D6 substrates because of marked species differences in CYP2D isoforms. To overcome this issue, a transgenic mouse line expressing the human CYP2D6 gene was generated. The complete...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
